ArticleBMC women's health2026
Policy window period: analysis of HPV vaccination status among age-eligible girls in China (before national immunisation programme implementation).
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyse the human papillomavirus (HPV) vaccination status among age-eligible girls in Fujian Province, China, during 2022–2023; to assess the relationship between vaccination rates and economic levels; and to provide scientific evidence to advance HPV vaccination programmes.
methodThe subjects of this study were girls aged 13-14.5 years in Fujian Province, China, from 2022 to 2023. The HPV vaccination information was collected from the Chinese Immunization Information System. The data on Gross Domestic Product (GDP) per capita and per capita disposable income were from the official statistical yearbook of Fujian Province.
resultsA total of 499,188 girls aged 13-14.5 years were vaccinated during the study period. The HPV vaccine coverage rate was 83.55%. The vaccination rate varied across 9 cities in Fujian province. The free vaccination rate was negatively correlated with GDP per capita and per capita disposable income. The self-funded vaccination rate was positively correlated with GDP per capita and per capita disposable income. For both free and self-paid vaccines, the strength of association was stronger for the first dose than for the second. For every 1 yuan increase in per capita disposable income, the free first-dose HPV vaccination coverage rate decreased by 0.569%. In contrast, the first-dose self-funded HPV vaccination coverage rate increased by 0.666%. Similarly, the second-dose free HPV vaccination coverage rate decreased by 0.509%, and the second-dose self-funded HPV vaccination coverage rate increased by 0.519%.
conclusionDuring the free domestic bivalent vaccine policy period, both GDP per capita and per capita disposable income influenced HPV vaccination rates, and the direction of this association showed opposite trends according to the type of vaccine (free or self-paid). Future strategies should transition from universal coverage to stratified precision approaches, implementing differentiated vaccine subsidy and supply policies based on regional economic development levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.